Figure 1.
PFS, EFS, and OS in the ITT population. Kaplan-Meier plot of (A) investigator-assessed PFS, (B) investigator-assessed EFS, and (C) OS in all randomized patients who received Pola-M-CHP vs Pola-R-CHP.

PFS, EFS, and OS in the ITT population. Kaplan-Meier plot of (A) investigator-assessed PFS, (B) investigator-assessed EFS, and (C) OS in all randomized patients who received Pola-M-CHP vs Pola-R-CHP.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal